Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers

Yuanlong Ge; Shu Wu; Zepeng Zhang; Xiaocui Li; Feng Li; Siyu Yan; Haiying Liu; Junjiu Huang; Yong Zhao

doi:10.1007/s13238-019-0640-1

Protein Cell ›› 2019, Vol. 10 ›› Issue (12) : 927 -928. DOI: 10.1007/s13238-019-0640-1

CORRECTION

Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers

Yuanlong Ge ¹^,²
, Shu Wu ¹^,²
, Zepeng Zhang ¹^,²
, Xiaocui Li ¹^,²
, Feng Li ¹
, Siyu Yan ¹
, Haiying Liu ¹^,²
, Junjiu Huang ¹
, Yong Zhao ¹^,²^,^†

Author information +

History +

PDF (519KB)

Cite this article

Download citation ▾

Yuanlong Ge, Shu Wu, Zepeng Zhang, Xiaocui Li, Feng Li, Siyu Yan, Haiying Liu, Junjiu Huang, Yong Zhao. Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers. Protein Cell, 2019, 10(12): 927-928 DOI:10.1007/s13238-019-0640-1